AdvanCell
AdvanCell is a clinical-stage radiopharmaceutical company developing innovative cancer therapeutics. The company focuses on targeted alpha therapies, with a lead program for metastatic prostate cancer, aiming to deliver life-changing treatments to cancer patients globally.
Funding Round: Series C
Funding Amount: $112M
Date: 03-Feb-2025
Investors: SV Health Investors, Sanofi Ventures, Abingworth, SymBiosis, Morningside, Tenmile, Brandon Capital
Markets: Biotech, Oncology, Therapeutics
HQ: Sydney, New South Wales, Australia
Founded: 2019
Website: https://www.advancell.com.au
LinkedIn: https://www.linkedin.com/company/advancell
Twitter: https://twitter.com/advancell_iso
Facebook: https://www.facebook.com/advancellisotopes
Crunchbase: https://www.crunchbase.com/organization/advancell
Leave a Comment
Comments
No comments yet.